Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03031847 · ClinicalTrials.gov registry record · NA
Cardiac Resynchronization in the Elderly
A NA study, sponsored by Samir Saba.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03031847: Completed NA study, sponsored by Samir Saba.
NCT03031847 is a NA study that has completed, run by Samir Saba. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03031847, a NA study, has completed, sponsored by Samir Saba.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
This pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed until study end. Rates of patient screening, enrollment, randomization, and retention as well as cost of care will be examined. The results of this pilot study will inform the design of a large pivotal non-inferiority trial and will be necessary for its success. Patients who refuse participation in the randomized pilot trial will be asked to enroll in a prospective observational cohort. Characteristics of patients who choose CRT-P vs. CRT-D will be compared and patients' level of satisfaction with their device decision will be measured.
Primary Outcome
Rates of enrollment of participants in this randomized trial
Interventions
- DEVICE Cardiac Resynchronization Therapy Pacemaker
- DEVICE Cardiac Resynchronization Therapy Defibrillator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-03-21 |
| Est. Completion | 2021-08-18 |
| Phase | NA |
What the finished NCT03031847 record still lists
NCT03031847 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Cardiac Resynchronization Therapy Pacemaker is the first listed.
NCT03031847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03031847 about?
NCT03031847 is a clinical study titled "Cardiac Resynchronization in the Elderly". This pilot will enroll 50 HF patients (age ≥ 75 years) undergoing CRT device implantation at the hospitals of the University of Pittsburgh Medical Center, Duke University, Ohio State University, and the VA Pittsburgh Healthcare System. Patients will be randomized to CRT-P versus CRT-D and followed u...
What is the current status of trial NCT03031847?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-03-21. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT03031847?
The interventions under investigation include: Cardiac Resynchronization Therapy Pacemaker (DEVICE), Cardiac Resynchronization Therapy Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT03031847?
This trial is sponsored by Samir Saba, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03031847's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI